3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
36
Neoplasms
32
Prostatic Neoplasms
26
Colorectal Neoplasms
25
Lung Neoplasms
21
Carcinoma, Non-Small-Cell Lung
16
Hematologic Neoplasms
13
Neoplasm Metastasis
10
Pancreatic Neoplasms
9
Ovarian Neoplasms
8
Multiple Myeloma
8
Head and Neck Neoplasms
8
Urinary Bladder Neoplasms
7
Triple Negative Breast Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Hematopoietic and Lymphatic System Neoplasm
7
Stomach Neoplasms
6
Carcinoma, Renal Cell
6
Anatomic Stage I Breast Cancer AJCC v8
6
Uterine Cervical Neoplasms
5
Sarcoma
5
Glioma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Mouth Neoplasms
4
Motor Activity
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Carcinoma
4
Gastrointestinal Neoplasms
4
Interventions
Nivolumab
3
capivasertib
2
Gemcitabine
2
Cisplatin
2
tivozanib
1
regorafenib
1
niraparib
1
neratinib
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
encorafenib
1
durvalumab
1
copanlisib
1
cemiplimab
1
axicabtagene ciloleucel
1
avasopasem manganese
1
Valproic Acid
1
Thioctic Acid
1
Taxes
1
Receptors, Interleukin-6
1
Radiosurgery
1
RNA-Seq
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
Standard of Care
×
1 year
×
Clear all
No trials found.